Best Practices for using AI to Summarize Congress Abstracts

AI is revolutionizing the role of Medical Science Liaisons (MSLs), allowing them to reduce time spent on administrative tasks to more strategic, personalized interactions with healthcare providers (HCPs). As the pharmaceutical industry undergoes a digital transformation, MSLs are using AI tools like predictive analytics and AI-generated insights to deliver data driven information and improve patient care. This article outlines best practices for MSLs when using AI to summarize congress abstracts.

Use a Secure and Industry Specific AI Model

  • Avoid general models: Never use publicly available tools like ChatGPT for summarizing medical abstracts. These models do not guarantee data privacy, and their training data is unknown, which risks breaching confidentiality.
  • Utilize secure, specialized models: Use proprietary AI tools designed for medical or scientific summarization. These systems are built to process large, complex datasets, understand specialized terminology, and often offer greater transparency on their training data.

Prompt Engineering-What is it?

Prompt engineering is how you tell an AI model what to do and how to do it. Users must learn how to formulate precise questions to guide an AI model, which, while trained to understand data, requires proper prompting to deliver accurate answers. This is where prompt engineering comes in! Think of it as the “language” users must learn to communicate effectively with an AI model to elicit the right information.

Key Best Practices for AI prompt Engineering

Specificity: Be precise with instructions to avoid vague/irrelevant outputs
  • Less specific: Tell me about heart disease.
  • More specific: “What are the most common risk factors for coronary artery disease?
Context: provide relevant background information such as disease area, drugs and patient populations to help the LLM understand the medical context
  • Before: Create a slide deck on Type 2 diabetes.
  • Optimized: Develop a 10-slide PowerPoint presentation on the latest Type 2 diabetes treatment guidelines, including first-line therapies, patient adherence strategies, and recent clinical trial findings. Target audience: healthcare providers.
Format: specify the desired output format (summary, list, table etc.)
  • Summarize the key efficacy and safety findings from the attached Phase 2 clinical trial data for [Drug Name] in [Disease Area]. Provide the summary as a threecolumn table

Source: https://medium.com/

Here are some prompts which are useful for MSLs:

What you want to do Prompt
Structure a basic but comprehensive summary “Summarize the following congress abstract for a medical affairs team. Focus on the background, methods, key findings, and conclusion, while highlighting the clinical significance.”
Analyze the competitive landscape “Based on the findings in this abstract, provide a summary of the competitive advantages and disadvantages of our therapeutic area.”
Combine and compare abstracts “Compare the results of the following two abstracts on [disease state]. Focus on the differences in study design, population, and overall conclusions.”
Generate follow-up questions “Generate five insightful scientific exchange questions for a Key Opinion Leader (KOL) based on the results and limitations of this abstract.”
Translate to actionable insights “Transform the results of this abstract into actionable insights for an MSL, including potential discussion points for KOLs and the potential impact on future research.” 

Audience Specific Summarization

To tailor the summary for different stakeholders, add specific words to your prompt.
Audience Key Prompt Words
For a medical affairs team Summarize, abstract, key findings, clinical significance,   background, methods, conclusions, implications, impact.
For a non-expert audience (e.g., patient advocacy) Lay summary, plain language, easy to understand, key takeaways for patients
For a leadership or executive audience Executive summary, concise, high level, strategic implications, competitive landscape
For a physician or clinician Clinical practice implications, relevance for treatment decisions, impact on patient care, standard of care

Source: https://pubmed.ncbi.nlm.nih.gov/

See How We Can Help!

Read how our inVision platform can help with prompt engineering!  inThought Labs understands the importance of prompt engineering and has invested significant effort in refining prompts to focus on patient safety, efficacy data, and new or changed information, resulting in more relevant and actionable summaries for MSLs. inVision works with clients to further refine prompts based on their unique focus areas, ensuring that the AI-generated summaries align with the clients’ evolving needs.

Published by: Doug Foster

Contact us

Learn how inThought Labs can simplify your life and empower your team with expert consultants and our cloud-based system, inVision.

Chris Martin

President

As the president of inThought Labs, Chris is focused on constantly improving inVision, the leading competitive and market intelligence platform for the biopharmaceutical industry, to better meet the changing needs of clients.

 

With 20 years of experience in roles being a consumer of market and competitive information, Chris understands the needs and priorities of clients. Chris was a senior principal and co-founder of inThought, a life science consulting, market research, and analytics firm. Collaborating with Ben Weintraub, Chris also co-founded BiotechTracker, an online tool for investors and precursor to inVision. Previous to inThought, he was a healthcare analyst and co-portfolio manager at two investment firms. Chris served in health care policy roles at the White House Office of Management and Budget. These roles included Medicare Desk Officer at the Office of Information and Regulatory Affairs, where he was responsible for providing recommendations to senior White House policy officials on healthcare policies and regulations.

 

Chris has a Master in Business Administration from Harvard Business School, a Master in Engineering from Villanova University, and a Bachelor of Science in Engineering from Cornell University. Prior to attending Harvard Business School, Chris served on two U.S. Navy nuclear submarines and at the Pentagon.